BioSpace News Archive

The global bone distractors market 2019-2023 is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, has added two global pharmaceutical senior executive veterans to its executive team to guide the company’s worldwide expansion across the pharmaceutical, managed care, healthcare provider and medical technology markets.

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that management will participate in the following upcoming investor conferences:

The Maximum Tender Offer for the 2020 Maximum Tender Offer Notes is referred to as the “2020 Notes Maximum Tender Offer” and the Maximum Tender Offer for the 2021 Maximum Tender Offer Notes is referred to as “2021 Notes Maximum Tender Offer”.

Drawbridge Health today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™ A1C Test System, comprised of the OneDraw Blood Collection Device and the OneDraw A1C Test.

Incyte Corporation announced that it will present at the following investor conferences during the month of September

A new report from Surescripts demonstrates how the nation’s leading health information network collaborated across the healthcare market to improve the accuracy of e-prescription transactions by 64% since 2016, leading to better e-prescribing quality, safety and cost.

Torque, a clinical-stage immuno-oncology company developing Deep-Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today the appointment of Sok Cheng Soh as Chief Financial Officer and Ana Radeljevic as Vice President, Head of Business Operations.

The Hazelden Betty Ford Foundation announced today the expansion of its Patient Care Network—the first of its kind in the addiction treatment industry—to include CentraCare, a Minnesota-based health system serving central, west central and southwest Minnesota.

However, facilities vary in the quality of care and services they provide residents.